These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3502019)

  • 1. Effect of intrastriatal and intranigral administration of synthetic neuromelanin on the dopaminergic neurotoxicity of MPTP in rodents.
    Melamed E; Soffer D; Rosenthal J; Pikarsky E; Reches A
    Neurosci Lett; 1987 Dec; 83(1-2):41-6. PubMed ID: 3502019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurotoxin MPTP does not affect striatal superoxide dismutase activity in mice.
    Pikarsky E; Melamed E; Rosenthal J; Uzzan A; Michowiz SD
    Neurosci Lett; 1987 Dec; 82(3):327-31. PubMed ID: 2827077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats.
    Lorenc-Koci E; Lenda T; Antkiewicz-Michaluk L; Wardas J; Domin H; Smiałowska M; Konieczny J
    Neurochem Int; 2011 Jun; 58(7):839-49. PubMed ID: 21419185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging.
    Date I; Yoshimoto Y; Imaoka T; Miyoshi Y; Gohda Y; Furuta T; Asari S; Ohmoto T
    Brain Res; 1993 Sep; 621(1):150-4. PubMed ID: 8106113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Martinovits G; Melamed E; Cohen O; Rosenthal J; Uzzan A
    Neurosci Lett; 1986 Aug; 69(2):192-7. PubMed ID: 3489911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Melamed E; Rosenthal J; Youdim MB
    J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats.
    Sonsalla PK; Zeevalk GD; Manzino L; Giovanni A; Nicklas WJ
    J Neurochem; 1992 May; 58(5):1979-982. PubMed ID: 1560247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice.
    Sundström E; Luthman J; Goldstein M; Jonsson G
    Brain Res Bull; 1988 Aug; 21(2):257-63. PubMed ID: 2903784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute electrophysiological and neurochemical effects of administration of MPTP in mice.
    Studer A; Sundström E; Jonsson G; Schultz W
    Neuropharmacology; 1988 Sep; 27(9):923-31. PubMed ID: 3263584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
    Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
    Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.
    Battaglia G; Busceti CL; Cuomo L; Giorgi FS; Orzi F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
    Neuropharmacology; 2002 Mar; 42(3):367-73. PubMed ID: 11897115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice.
    Wu WR; Zhu XZ
    Life Sci; 1999; 65(2):157-64. PubMed ID: 10416821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.